XOMA Corp (XOMA)

NASDAQ
19.03
-1.05(-5.23%)
  • Volume:
    68,213
  • Day's Range:
    18.60 - 19.83
  • 52 wk Range:
    16.96 - 32.49

XOMA Overview

Prev. Close
20.08
Day's Range
18.6-19.83
Revenue
40.98M
Open
19.83
52 wk Range
16.96-32.49
EPS
0.84
Volume
68,213
Market Cap
217.91M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
54,902
P/E Ratio
25.97
Beta
0.866
1-Year Change
-35.54%
Shares Outstanding
11,450,823
Next Earnings Date
Nov 09, 2022
What is your sentiment on XOMA?
or
Market is currently closed. Voting is open during market hours.

XOMA Corp News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

XOMA Corp Analysis

XOMA Corp Company Profile

XOMA Corp Company Profile

Employees
12

XOMA Corporation is a biotechnology royalty aggregator. The Company’s drug royalty aggregator business is focused on early to mid-stage clinical assets, primarily in Phase I and II. The Company has a portfolio of economic rights and royalty payments associated with partnered pre-commercial therapeutic candidates. It also acquires the economics associated with pre-commercial therapeutic candidates that are licensed to pharmaceutical or biotechnology companies. The Company has a portfolio of more than 70 assets. Its royalty portfolio includes NIS793, anti-transforming growth factor-beta (TGFb) antibody program; gevokizumab (VPM087), a clinical-stage anti-IL-1b product candidate; scalimab (CFZ533); mezagitamab (TAK-079); RZ358; AZD2936, a TIGIT/PD-1 bispecific antibody; MK-4830, and others. The Company's geographical segments include Europe, United States and Asia Pacific.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellSellStrong SellStrong Sell
Technical IndicatorsBuyBuyStrong SellStrong SellStrong Sell
SummaryNeutralNeutralStrong SellStrong SellStrong Sell